Clinical Report: Efficacy and Safety of Native Tissue Repair vs Transvaginal Mesh

Overview

This study compares the efficacy and safety of native tissue repair (NTR) and transvaginal mesh (TVM) in managing uterine prolapse. Results indicate that while both methods improve symptoms, TVM shows a lower recurrence rate but a higher complication rate compared to NTR.

Background

Uterine prolapse significantly impacts women's quality of life, necessitating effective surgical interventions. Native tissue repair and transvaginal mesh are two primary surgical options, each with distinct advantages and risks. Understanding their comparative efficacy and safety is crucial for informed clinical decision-making.

Data Highlights

Key Findings

• The average operation time was significantly shorter for the TVM group (148.8 min) compared to the NTR group (177.3 min).
• Patients in the TVM group had a longer average hospital stay (6.49 days) than those in the NTR group (5.51 days).
• Both groups showed significant improvement in postoperative PFDI-20 and PFIQ-7 scores.
• The overall complication rate was higher in the TVM group (30.61%) compared to the NTR group (10.81%).
• The recurrence rate within one year was lower in the TVM group (4.08%) than in the NTR group (18.92%).

Clinical Implications

Clinicians should consider the trade-offs between the lower recurrence rates associated with transvaginal mesh and the higher complication rates when discussing surgical options with patients. A thorough assessment of individual patient circumstances is essential for optimal surgical decision-making.

Conclusion

Both native tissue repair and transvaginal mesh are effective in managing uterine prolapse, but they present different risk profiles. Careful consideration of these factors is necessary to guide treatment choices.

Related Resources & Content

1. FDA, U.S. Food and Drug Administration, 2026 -- Urogynecologic Surgical Mesh Implants
2. PROSPECT: 4- and 6-year follow-up of a randomised trial of surgery for vaginal prolapse - PMC
3. Approaches to Addressing Viscus Perforation in Patients After Pelvic Mesh Procedures, 2025 -- Springer
4. Clinical study on the application of biological mesh and synthetic mesh in laparoscopic inguinal hernia repair, 2026 -- Langenbeck's Archives of Surgery
5. Evaluating the Necessity of Mesh in Small Umbilical Hernia Repairs, 2020 -- Hernia
6. Hernia — Changes in Mesh Size Over Time in Retromuscular and Intraperitoneal Approaches for Incisional Hernia Repair: Insights from a Randomized Controlled Trial and Literature Review
7. Urogynecologic Surgical Mesh Implants | FDA
8. PROSPECT: 4- and 6-year follow-up of a randomised trial of surgery for vaginal prolapse - PMC